Cerenome
Clinical trials sponsored by Cerenome, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Radioactive nanoparticles aimed at cancer that spreads to the Brain's lining Results expected Oct 2026 (estimated)
-
Radioactive gel aimed straight at childhood brain tumors
Disease control Recruiting nowResearchers are testing a radioactive gel called rhenium-186 obisbemeda in children and young adults, ages 6 to 21, whose ependymoma or high-grade glioma has come back or keeps growing after treatment. The gel is infused directly into the tumor through a thin tube, a method calle…
Phase 1 • Sponsor: Cerenome • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Radioactive nanoparticles aimed at cancer that spreads to the Brain's lining
Disease control Recruiting nowResearchers are testing a radioactive drug called rhenium-186 obisbemeda in adults whose solid-tumor cancer has spread to the leptomeninges, the tissues lining the brain and spinal cord. The drug is a nanoliposome carrying rhenium-186, a radioactive isotope, and it is given throu…
Phase 1/2 • Sponsor: Cerenome • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC